Evidence of Epigenetic Oncogenesis: A Turning Point in Cancer Research
BioEssays · 2025
DOI: 10.1002/bies.202400183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioEssays, 2025. Verfasst von Jean-Pascal Capp und 2 weiteren Autor:innen. Beteiligte Einrichtung: Toulouse Biotechnology Institute, INSA/University of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association pour la Recherche sur le Cancer, Agence Nationale de la Recherche.
Abstract (Originalsprache)
In cancer research, the term epigenetics was used in the 1970s in its modern sense encompassing non‐genetic events modifying the chromatin state, mainly to oppose the emerging oncogene paradigm. However, starting from the establishment of this prominent concept, the importance of these epigenetic phenomena in cancer rarely led to questioning the causal role of genetic alterations. Only in the last 10 years, the accumulation of problematic data, better experimental technologies, and some ambitious models pushed the idea that epigenetics could be at least as important as genetics in early oncogenesis. Until this year, a direct demonstration of epigenetic oncogenesis was still lacking. Now, Parreno, Cavalli and colleagues, using a refined experimental model in the fruit fly Drosophila melanogaster , enforced the initiation of tumors solely by imposing a transient loss of Polycomb repression, leading to a purely epigenetic oncogenesis phenomenon. Despite a few caveats that we discuss, this pioneering work represents a major breakpoint in cancer research. We are led to consider the theoretical and conceptual implications on oncogenesis and to search for links between this artificial experimental model and naturally occurring processes, while revisiting cancer theories that were previously proposed as alternatives to the oncogene‐centered paradigm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Toulouse Biotechnology Institute, INSA/University of Toulouse, Toulouse, France.
- CRCT, Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Toulouse, France.
ORCID-Profile: Jean-Pascal Capp, Benoît Aliaga
Förderung
- Association pour la Recherche sur le Cancer
- Agence Nationale de la Recherche
Zitieren
APA
Capp, J. P., Aliaga, B., & Pancaldi, V. (2025). Evidence of Epigenetic Oncogenesis: A Turning Point in Cancer Research. BioEssays. https://doi.org/10.1002/bies.202400183
Vancouver
Capp JP, Aliaga B, Pancaldi V. Evidence of Epigenetic Oncogenesis: A Turning Point in Cancer Research. BioEssays. 2025. doi:10.1002/bies.202400183
BibTeX
@article{Capp2025,
author = {Capp, Jean-Pascal and Aliaga, Benoît and Pancaldi, Vera},
title = {Evidence of Epigenetic Oncogenesis: A Turning Point in Cancer Research},
journal = {BioEssays},
year = {2025},
doi = {10.1002/bies.202400183}
}
EUVIMED